Over half a million children lose their lives to diarrhea each year. While safe, effective, and affordable treatment and prevention methods are currently available, they have not always been widely adopted and do not offer comprehensive protection against diarrhea’s long-term effects, including malnutrition, stunting, and deficits in cognitive development. Together, these effects may contribute to a condition known as enteric enteropathy, which can devastate the health and productivity of communities around the world. The Diarrhea Innovations Group (DIG) seeks to defeat diarrhea and address these long-term effects through global collaboration.
What is the Diarrhea Innovations Group (DIG)?
DIG is a global network of innovators committed to reducing child deaths from diarrhea through the development of new diagnostic and therapeutic technologies and approaches. The group includes broad representation from academic, nonprofit, public, and private sectors.
Why was it created?
To accelerate the development and adoption of new diagnostic and therapeutic technologies with the greatest potential to reduce child deaths from diarrhea with an emphasis on countries in Africa and Asia that bear the highest diarrheal disease burden.
--> Serve as a venue for members to share knowledge, exchange information, and discuss new ideas.
--> Create and maintain an up-to-date inventory of innovative diarrhea diagnostics and therapeutics under development.
--> Identify current normative guidelines and regulatory directives (e.g. stringent regulatory authorities, national regulatory authorities, World Health Organization) influencing and regulating diarrheal disease innovations.
--> Provide a regular, bi-monthly forum for crowd sourcing solutions to bottlenecks, challenges, etc.
--> Serve as a venue to match innovators with potential investors and partners.
Are you interested in joining DIG?
To join the network listserv, please email firstname.lastname@example.org.
· Diarrhea Innovations Group meeting at ASTMH, Atlanta, GA
Date: Sunday, November 13, 2016 | Time: 1:00 to 4:30 p.m.
To participate, contact PATH Drug Development.
· DIG held its first in-person meeting in Washington, DC on November 5, 2015.
Photo, top of page, courtesy of the Bill & Melinda Gates Foundation.